United Kingdom· GB-APID-23621711000001102
Relvar Ellipta 184micrograms/dose / 22micrograms/dose dry powder inhaler
A medicinal product containing fluticasone + vilanterol, registered in United Kingdom by GlaxoSmithKline UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fluticasone + Vilanterol
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5000123113996
- gtin5000123115471
- gtin05054290002416
- gtin5054290010046
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluticasone + vilanterol in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainRELVAR ELLIPTA 184 MCG/22 MCG POLVO PARA INHALACION (UNIDODIS)Glaxosmithkline Trading Services Limited
- FinlandRelvar Ellipta2care4 ApS
- NorwayRelvar ElliptaGlaxoSmithKline Trading Services Limited
- SwedenRELVAR ELLIPTA 184 mikrogram/22 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- SwitzerlandRelvar Ellipta 184/22 mcg, Einzeldosiertes Pulver zur InhalationGlaxoSmithKline AG
- PolandRelvar ElliptaGlaxoSmithKline (Ireland) Limited
- CanadaBREO ELLIPTAGLAXOSMITHKLINE INC
- IrelandRevinty Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensedGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Relvar Ellipta, Revinty Ellipta
- Liechtenstein · Relvar Ellipta, Revinty Ellipta
- Norway · Relvar Ellipta, Revinty Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efb668cf-8e45-4394-b559-652a8192bb86 GET /v1/drugs/efb668cf-8e45-4394-b559-652a8192bb86?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23621711000001102",
"desc": "Relvar Ellipta 184micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)",
"form": "Inhalation powder",
"vpid": "23661311000001105",
"source": "dmd",
"vtm_id": "776019001",
"strength": "184 microgram",
"substance": "Fluticasone + Vilanterol",
"ingredient": "Fluticasone furoate",
"supplier_code": "4012301000001105"
}See everything about fluticasone + vilanterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.